VRTX(Vertex Pharmaceuticals Incorporated) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $7.57B | $8.93B | $9.87B | $11.02B | $12.00B |
| 毛利润 | $6.67B | $7.85B | $8.61B | $9.49B | $10.35B |
| 营业利润 | $2.78B | $4.31B | $3.83B | −$232.90M | $4.17B |
| 净利润 | $2.34B | $3.32B | $3.62B | −$535.60M | $3.95B |
| 经营现金流 | $2.64B | $4.13B | $3.54B | −$492.60M | $3.63B |
| 自由现金流 | $2.41B | $3.93B | $3.34B | −$790.30M | $3.19B |
| 摊薄每股收益 | $9.01 | $12.82 | $13.89 | $-2.08 | $15.32 |